LOS ANGELES, Sept. 13, 2021 /PRNewswire/ -- Max BioPharma, Inc. (www.maxbiopharma.com) recently published an article that reported the efficacy of its anti-fibrotic and anti-inflammatory oxysterol ...
SAN FRANCISCO--(BUSINESS WIRE)--FibroGen, Inc., today announced proof-of-principle for oral anemia therapy FG-4592, a hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor (PHI), in end-stage ...
Johns Hopkins Medicine researchers say they have successfully used a cell's natural process for making proteins to "slide" genetic instructions into a cell and produce critical proteins missing from ...
– Milestone Triggers Two Single-Digit Multimillion-Dollar Payments to Dicerna – LEXINGTON, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ...
Alliqua, Inc. (OTCQB: ALQA) ("Alliqua" or the "Company") today announced the initiation of a preclinical proof-of-principle study of an experimental hydrogel patch containing lidocaine. Safety and ...
All products featured on Wired are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. James Clarke, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results